Ventricular tachycardia.
D000200:Action Potentials; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001794:Blood Pressure; D001949:Bretylium Compounds / Q000627:therapeutic use; D005117:Cardiac Complexes, Premature / Q000503:physiopathology; D004554:Electric Countershock; D004562:Electrocardiography; D006326:Heart Auscultation; D006329:Heart Conduction System / Q000503:physiopathology*; D006352:Heart Ventricles; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide